KPV | Inflammatory Signaling Research Peptide

KPV—short for lysine-proline-valine—is a compact tripeptide derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). It is studied for its potential to modulate inflammatory signaling while retaining key properties associated with the parent melanocortin peptide.

Preclinical research suggests that KPV can reduce activation of NF-κB, a transcription factor involved in regulating inflammatory mediators and cellular stress responses. Through this pathway, KPV has been investigated for its effects on cytokine signaling, immune-cell activity, and inflammatory responses within epithelial tissue.

KPV is also studied in gastrointestinal research because it can interact with the PepT1 peptide transporter, providing a potential mechanism for cellular uptake within intestinal tissue. Cell and animal studies have examined its effects on mucosal inflammation, epithelial integrity, and immune–epithelial communication.

These properties make KPV a valuable research tool for investigating inflammatory signaling, intestinal barrier biology, melanocortin-derived pathways, and cellular responses to tissue stress.

Supplied at 10 mg per vial.

For laboratory research use only. Not for human consumption, diagnostic use, or therapeutic use.